MED1 and cancer: The promoter region of MED1 (mediator complex subunit 1), one of the optimized aberrant methylated gene associated with cancers, was reported to be frequently methylated in ovarian and colorectal cancer cell lines and this had been to result in the low expression of MED1 [37].